These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 26562695
21. Prevalence, clearance, and incidence of human papillomavirus type-specific infection at the anal and penile site of HIV-infected men. Darwich L, Cañadas MP, Videla S, Coll J, Molina-López RA, Sirera G, Clotet B, Can Ruti HIV-HPV Team. Sex Transm Dis; 2013 Aug; 40(8):611-8. PubMed ID: 23859907 [Abstract] [Full Text] [Related]
22. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men. Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, Wieland U. J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122 [Abstract] [Full Text] [Related]
23. Prophylactic HPV vaccination and anal cancer. Stier EA, Chigurupati NL, Fung L. Hum Vaccin Immunother; 2016 Jun 02; 12(6):1348-51. PubMed ID: 26933898 [Abstract] [Full Text] [Related]
24. Human Papillomavirus Positivity in the Anal Canal in HIV-Infected and HIV-Uninfected Men Who Have Anal Sex with Men in Guangzhou, China: Implication for Anal Exams and Early Vaccination. Ren X, Ke W, Zheng H, Yang L, Huang S, Qin X, Yang B, Zou H. Biomed Res Int; 2017 Jun 02; 2017():2641259. PubMed ID: 28133605 [Abstract] [Full Text] [Related]
27. Assessing urine human papillomavirus polymerase chain reaction testing as a tool for screening anal HPV infection in HIV-positive MSM. Lanoix JP, Pannier C, Borel A, El Samad Y, Robin C, Douadi Y, Woimant M, Fouche B, Lecaque C, Ganry O, Duverlie G, Sevestre H, Schmit JL. AIDS Patient Care STDS; 2012 Apr 02; 26(4):208-13. PubMed ID: 22320265 [Abstract] [Full Text] [Related]
29. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Swedish KA, Factor SH, Goldstone SE. Clin Infect Dis; 2012 Apr 02; 54(7):891-8. PubMed ID: 22291111 [Abstract] [Full Text] [Related]
32. Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. Hillman RJ, Garland SM, Gunathilake MP, Stevens M, Kumaradevan N, Lemech C, Ward RL, Meagher A, McHugh L, Jin F, Carroll S, Goldstein D, Grulich AE, Tabrizi SN. Int J Cancer; 2014 Aug 15; 135(4):996-1001. PubMed ID: 24497322 [Abstract] [Full Text] [Related]
33. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Videla S, Darwich L, Cañadas MP, Coll J, Piñol M, García-Cuyás F, Molina-Lopez RA, Cobarsi P, Clotet B, Sirera G, HIV-HPV Study Group. Sex Transm Dis; 2013 Jan 15; 40(1):3-10. PubMed ID: 23250297 [Abstract] [Full Text] [Related]
34. Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan. Nagata N, Watanabe K, Nishijima T, Tadokoro K, Watanabe K, Shimbo T, Niikura R, Sekine K, Akiyama J, Teruya K, Gatanaga H, Kikuchi Y, Uemura N, Oka S. PLoS One; 2015 Jan 15; 10(9):e0137434. PubMed ID: 26368294 [Abstract] [Full Text] [Related]
40. Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination. Zhou Y, Lin YF, Meng X, Duan Q, Wang Z, Yang B, Zheng H, Li P, Li M, Lu Y, Luo Z, Zou H. Vaccine; 2020 Mar 17; 38(13):2849-2858. PubMed ID: 32088017 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]